breast cancer - triple negative | ||
mBC - TNBC - L1 - all population | mBC - TNBC - L1 - PDL1 positive | |
atezolizumab plus nab-paclitaxel | IMpassion-130 ... | IMpassion-130 ... |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -